المواد المؤثرة على العقل (لا تزال) تقصر عن التوقعات في التجارب السريرية.

Psychedelics like psilocybin offer groundbreaking potential for treating mental health disorders, providing hope where traditional therapies have failed.

Relying on mind-altering substances for mental health treatment risks over-medication and neglecting holistic approaches like therapy and lifestyle changes.

Psychedelics could revolutionize addiction treatment, offering unique mechanisms that could help individuals break free from cycles of substance abuse.

The clinical trial results for psychedelics are mixed, indicating that while some patients benefit, many others do not, necessitating careful consideration before widespread use.

The hype around psychedelics in clinical trials may overshadow the need for rigorous scientific evaluation, potentially leading to premature acceptance in healthcare.